{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:31:08Z","timestamp":1775597468472,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"B\u00fcrgermeisterfonds der Stadt Wien","award":["14024"],"award-info":[{"award-number":["14024"]}]},{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00508-018-1386-0","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T02:27:28Z","timestamp":1535682448000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Rheumatoid arthritis in remission"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-7532","authenticated-orcid":false,"given":"Katharina","family":"Kerschan-Schindl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerold","family":"Ebenbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"F\u00f6eger-Samwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Leiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Gesslbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malvina","family":"Herceg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Stummvoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Crevenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"1386_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0167-5273(02)00237-1","volume":"85","author":"J Walsmith","year":"2002","unstructured":"Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Internat J Cardiol. 2002;85:89\u201399.","journal-title":"Internat J Cardiol"},{"key":"1386_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler ALSJ. Regulation of skeletal muscle mass in mice by a\u00a0new TNF-\u00df superfamily member. Nature. 1997;387:83\u201390.","journal-title":"Nature"},{"key":"1386_CR3","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1152\/ajpendo.00193.2009","volume":"297","author":"H Gilson","year":"2009","unstructured":"Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab. 2009;297:E157\u2013E64.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1386_CR4","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","volume":"285","author":"K Ma","year":"2003","unstructured":"Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endorcinol Metab. 2003;285:E363\u2013E71.","journal-title":"Am J Physiol Endorcinol Metab"},{"key":"1386_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1210\/en.2006-0539","volume":"148","author":"H Gilson","year":"2007","unstructured":"Gilson H, Schakman O, Combaret L, et al. Myostatin gene depletion prevents glucocorticoids-induced muscle atrophy. Endocrinology. 2007;148:452\u201360.","journal-title":"Endocrinology"},{"key":"1386_CR6","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci Usa. 2001;98:9306\u201311.","journal-title":"Proc Natl Acad Sci Usa"},{"key":"1386_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13539-012-0082-6","volume":"3","author":"VW Tsai","year":"2012","unstructured":"Tsai VW, Husaini Y, Manandhar R, et al. Naorexia\/cachexia of chronic diseases: a\u00a0role for the TGF-\u00df family cytokine MIC-1\/GDF15. J\u00a0Cachexia Sarcopenia Muscle. 2012;3:239\u201343.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1386_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1210\/er.2011-1060","volume":"33","author":"HZ Ke","year":"2012","unstructured":"Ke HZ, Richards WG, Li X, Ominsky MS. Sclerostin and Dickkopf-1 as therapeutic targets in bone disease. Endocr Rev. 2012;33:747\u201383.","journal-title":"Endocr Rev"},{"key":"1386_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bone.2014.05.016","volume":"66","author":"P Garnero","year":"2014","unstructured":"Garnero P. New developments in biological markers of bone metabolism in osteoporosis. Bone. 2014;66:46\u201355.","journal-title":"Bone"},{"key":"1386_CR10","first-page":"362","volume":"36","author":"K Britsemmer","year":"2018","unstructured":"Britsemmer K, van Schaardenburg D, Boers M, et\u00a0al. Prevalence and validity of ACR\/EULAR remission in four European early rheumatoid arthritis cohorts. Clin Exp Rheumatol. 2018;36:362\u201370.","journal-title":"Clin Exp Rheumatol"},{"key":"1386_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","volume":"63","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, et\u00a0al. American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63:573\u201386.","journal-title":"Arthritis Rheum"},{"key":"1386_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199503023320902","volume":"332","author":"JM Guralnik","year":"1995","unstructured":"Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower extremity function over the age of 70 years as a\u00a0predictor of subsequent disability. N\u00a0Eng J Med. 1995;332:556\u201361.","journal-title":"N Eng J Med"},{"key":"1386_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed \u201cUp & Go\u201d: a\u00a0test of basic functional mobility for frail elderly persons. J\u00a0Am Geriatr Soc. 1991;39:142\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1386_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1034\/j.1399-3003.1999.14b06.x","volume":"14","author":"T Troosters","year":"1999","unstructured":"Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir\u00a0J. 1999;14:270\u20134.","journal-title":"Eur Respir J"},{"key":"1386_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0363-5023(84)80146-X","volume":"9","author":"V Mathiowetz","year":"1984","unstructured":"Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J\u00a0Hand Surg Am. 1984;9:222\u20136.","journal-title":"J Hand Surg Am"},{"key":"1386_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ptj\/73.1.3","volume":"73","author":"MT Moffroid","year":"1993","unstructured":"Moffroid MT, Haugh LD, Haig AJ, Henry SM, Pope MH. Endurance training of trunk extensor muscles. Phys Ther. 1993;73:10\u20137.","journal-title":"Phys Ther"},{"key":"1386_CR17","first-page":"1245","volume":"21","author":"P Br\u00fchlmann","year":"1994","unstructured":"Br\u00fchlmann P, Stucki G, Michel BA. Evaluation of a\u00a0German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. J\u00a0Rheumatol. 1994;21:1245\u20139.","journal-title":"J Rheumatol"},{"key":"1386_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health contructs. Med Care. 1993;31:247\u201363.","journal-title":"Med Care"},{"key":"1386_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","volume":"32","author":"CA McHorney","year":"1994","unstructured":"McHorney CA, Ware JE, Lu R, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40\u201366.","journal-title":"Med Care"},{"key":"1386_CR20","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a\u00a0review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23:S100\u2013S8.","journal-title":"Clin Exp Rheumatol"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"E790","DOI":"10.1152\/ajpendo.00590.2010","volume":"300","author":"E Castillero","year":"2011","unstructured":"Castillero E, Nieto-Bons MP, Fernandez-Galaz C, et al. Fenofibrate, a\u00a0PPAR\u03b1 agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy. Am J Physiol Endocrinol Metab. 2011;300:E790\u2013E9.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1386_CR22","first-page":"707","volume":"22","author":"Y Ehara","year":"2004","unstructured":"Ehara Y, Sakurai D, Tsuchiya N, et al. Follistatin-related proterin gene (FRP) is expressed in the synovial tissues if rheumatoid arthritis, but its polymorphisms are not associated with genetic susceptibility. Clin Exp Rheumatol. 2004;22:707\u201312.","journal-title":"Clin Exp Rheumatol"},{"key":"1386_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","volume":"83","author":"JE Morley","year":"2006","unstructured":"Morley JE, Thomas DR, Cachexia WMM. pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83:735\u201343.","journal-title":"Am J Clin Nutr"},{"key":"1386_CR24","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1113\/jphysiol.2009.178319","volume":"587","author":"I Rieu","year":"2009","unstructured":"Rieu I, Magne H, Savary-Auzeloux I, et al. Reduction of low grade inflammation restores blunting of postbrandial muscle anabolism and limits sarcopenia in old rats. J\u00a0Physiol. 2009;587:5483\u201392.","journal-title":"J Physiol"},{"key":"1386_CR25","first-page":"66","volume":"42","author":"O Tanrikulu","year":"2017","unstructured":"Tanrikulu O, Sanyildiz MA, Batmaz I, et al. Serum GDF-15 level in rheumatoid arthritis: relationship with disease activity, and subclinical atherosclerosis. Acta Reumatol Port. 2017;42:66\u201372.","journal-title":"Acta Reumatol Port"},{"key":"1386_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00223-016-0161-3","volume":"99","author":"G Adami","year":"2016","unstructured":"Adami G, Orsolini G, Adami S, et\u00a0al. Effects of TNF inhibitors on parathyroid hormone and Wnt signaling antagonists in rheumatoid arthritis. Calcif Tissue Int. 2016;99:360\u20134.","journal-title":"Calcif Tissue Int"},{"key":"1386_CR27","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1210\/jc.2013-3893","volume":"99","author":"JC Rousseau","year":"2014","unstructured":"Rousseau JC, Sornay-Rendu E, Bertholon C, Chapurlat R, Garnero P. Serum periostin is associated with fracture risk in postmenopausal women: a\u00a07-year prospective analysis of the OFELY study. J\u00a0Clin Endocrinol Metab. 2014;99:2533\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1386_CR28","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1073\/pnas.0604893104","volume":"104","author":"H Amthor","year":"2007","unstructured":"Amthor H, Macharia R, Navarrete R, et\u00a0al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S\u00a0A. 2007;104:1835\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1386_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/gerona\/glu147","volume":"70","author":"M Pauly","year":"2015","unstructured":"Pauly M, Chabi B, Favier FB, et al. Combined strategies for maintaining skeletal muscle mass and function in aging: myostatin inactivation and AICAR-associated oxidative metabolism induction. J\u00a0Gerontol A Biol Sci Med Sci. 2015;70:1077\u201387.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1386_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2016.06.002","volume":"433","author":"JS Hansen","year":"2016","unstructured":"Hansen JS, Plomgaard P. Circulating follistatin in relation to energy metabolism. Mol Cell Endocrinol. 2016;433:87\u201393.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-018-1386-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-018-1386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T07:04:50Z","timestamp":1567235090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-018-1386-0"}},"subtitle":["Decreased myostatin and increased serum levels of periostin"],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s00508-018-1386-0","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"22 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Kerschan-Schindl, G.\u00a0Ebenbichler, U.\u00a0F\u00f6eger-Samwald, H.\u00a0Leiss, C.\u00a0Gesslbauer, M.\u00a0Herceg, G.\u00a0Stummvoll, R.\u00a0Marculescu, R.\u00a0Crevenna, and P.\u00a0Pietschmann declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}